Refert 50mg Tablet
Marketer
Sanzyme Ltd
Salt Composition
Clomiphene (50mg)
Overview Refert 50mg Tablet
Reftin 50mg tablets help women overcome infertility issues stemming from ovulation disorders or polycystic ovary syndrome (PCOS). Intended for infertility treatment, this medication should be taken precisely as directed and is not suggested for use beyond three menstrual cycles. Common, typically transient, side effects may include facial flushing, abdominal discomfort, breast tenderness, and visual disturbances. Persistent symptoms warrant immediate medical attention.
Uses of Refert 50mg Tablet
Managing infertility in women
Major Benefits of Refert 50mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 50mg Refert Tablet can be administered with or without food, although consistent timing is recommended.
Common Side effects of Refert 50mg Tablet:
- Nausea
- Vomiting
- Bloating
- Headache
- Enlarged ovary
- Hot flashes
- Metrorrhagia (menstrual bleeding at irregular intervals)
- Breast discomfort
- Visual disorder
How to use Refert 50mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. The 50mg Refert Tablet can be consumed with or without food, although consistent timing is recommended.
How Refert 50mg Tablet works:
Fertility aid Refert 50mg tablets function as a selective estrogen receptor modulator (SERM), facilitating conception in women. The medication achieves this by boosting reproductive hormone production, thereby triggering the ovaries to release eggs (ovulation).
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Refert 50mg tablets and alcohol. Seek medical advice.
PregnancyUNSAFE
Employing Refert 50mg tablets during pregnancy poses a considerable risk. Pregnant individuals should consult their physician; research in animal and human studies indicates substantial adverse effects on fetal development.
Breast feedingCONSULT YOUR DOCTOR
Administration of Refert 50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a 50mg Refert Tablet may temporarily blur your vision. Refrain from driving until your vision returns to normal.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Refert 50mg Tablets in individuals with renal impairment. Physician consultation is advised.
LiverUNSAFE
Patients with liver conditions should not take Refert 50mg Tablets; use is strongly discouraged. Medical advice is recommended.
What if you forget to take Refert 50mg Tablet :
Should you forget to take a Refert 50mg Tablet, seek your physician's advice.
Facts to Know About Refert 50mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Stilbene Derivative of Triphenylethylene |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
3,018 People bought this recently